Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo.
Shenglin LuJun Li
Published in: Asian biomedicine : research, reviews and news (2024)
In vivo silencing of VEGF can affect cell survival and inhibit cell migration, invasion, and development, probably by enhancing apoptosis and inhibiting the expressions of MMP2 and MMP9.